Editorial: genotype 3 HCV-who still needs ribavirin in a pan-genotypic era? Authors' reply

Aliment Pharmacol Ther. 2018 Jun;47(11):1550-1551. doi: 10.1111/apt.14648.

J von Felden^{1

2}, J Vermehren³, J Schulze Zur Wiesch^{1

4}, C Sarrazin^{3

5}, S Christensen⁶

¹ I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
² Divisions of Liver Diseases and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
³ Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt, Germany.
⁴ German Center for Infection Research (DZIF), Hamburg-site, Germany.
⁵ St. Josef's Hospital, Wiesbaden, Germany.
⁶ CIM Infectious diseases, Muenster, Germany.

No abstract available

Publication types